| Not Yet Recruiting | Azoles Targeting Recurrent High Grade Gliomas NCT03763396 | University Health Network, Toronto | EARLY_Phase 1 |
| Withdrawn | Early Temozolomide in Patients With High-Grade Gliomas in Rehabilitation NCT03796507 | University of Rochester | EARLY_Phase 1 |
| Terminated | Precise DCE-MRI in Diagnosing Participants With Recurrent High Grade Glioma or Melanoma Brain Metastases NCT03698162 | University of Southern California | N/A |
| Unknown | A Large-scale Research for Immunotherapy of Glioblastoma With Autologous Heat Shock Protein gp96 NCT03650257 | Cure&Sure Biotech Co., LTD | Phase 2 |
| Unknown | Efficacy of Kangliuwan for Recurrent Grade IV Glioma NCT03949192 | Xuanwu Hospital, Beijing | — |
| Terminated | Intratumorally-Administered Topotecan Using Convection-Enhanced Delivery in Patients With Grade III/ IV Glioma NCT03927274 | H. Lee Moffitt Cancer Center and Research Institute | EARLY_Phase 1 |
| Completed | Safety and Efficacy of L19TNF in Patients With Isocitrate Dehydrogenase (IDH) Wildtype WHO Grade III / IV Glio NCT03779230 | Philogen S.p.A. | Phase 1 / Phase 2 |
| Unknown | V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer NCT03916757 | Immunitor LLC | Phase 2 |
| Recruiting | A Study Utilizing Escitalopram in Glioma Patients NCT03728673 | University of Nebraska | Phase 2 |
| Active Not Recruiting | Pilot Study of Mirtazapine for the Dual Tx of Depression and CINV in High-Grade Glioma Pts on TMZ NCT03935685 | University of California, Irvine | Phase 2 |
| Terminated | Seizure Prophylaxis in Patients With Glioma or Brain Metastasis NCT03436433 | Duke University | Phase 2 |
| Completed | A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade G NCT03834740 | St. Joseph's Hospital and Medical Center, Phoenix | EARLY_Phase 1 |
| Unknown | Visual Study of Molecular Genotype in Glioma Evolution NCT03750890 | Tongji Hospital | — |
| Active Not Recruiting | Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With NCT03739372 | University of California, San Francisco | N/A |
| Completed | Pembrolizumab in Association With the IMA950/Poly-ICLC for Relapsing Glioblastoma NCT03665545 | University Hospital, Geneva | Phase 1 / Phase 2 |
| Completed | Evaluation of Functional Magnetic Resonance Imaging (fMRI) in Patients Who Speak Two Languages Fluently NCT03496181 | Memorial Sloan Kettering Cancer Center | — |
| Completed | Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy f NCT03194906 | St. Jude Children's Research Hospital | Phase 2 |
| Recruiting | Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM NCT03213002 | Northwell Health | Phase 1 / Phase 2 |
| Unknown | The Efficacy of APT Magnetic Resonance Imaging in Predicting the Efficacy of Bevacizumab in Recurrent Malignan NCT03180697 | Zhujiang Hospital | — |
| Unknown | Noninvasively Predicting Gene Status of Glioma NCT03102112 | Tang-Du Hospital | — |
| Active Not Recruiting | Glioma Microenvironment an Exploratory Study NCT03189420 | Hospital Sirio-Libanes | — |
| Recruiting | Neuropsychological and Oncological Outcomes in Grade 2 or 3 Glioma Patients Undergoing Postoperative Modern Ra NCT03534050 | Chang Gung Memorial Hospital | Phase 2 / Phase 3 |
| Recruiting | Longitudinal Analysis of the Health-related Quality of Life in Glioma Patients NCT03849430 | Universitaire Ziekenhuizen KU Leuven | — |
| Withdrawn | CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients NCT04406610 | Fuda Cancer Hospital, Guangzhou | Phase 1 / Phase 2 |
| Terminated | Blood Biomarker Signature in Glioma NCT03698201 | Cancer Trials Ireland | — |
| No Longer Available | An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas NCT03460782 | Center Trials & Treatment | — |
| No Longer Available | Expanded Access for Pembrolizumab (MK-3475) NCT03311542 | Center Trials & Treatment | — |